QIAGEN reports strong results for third quarter and first nine months of 2020 and increases outlook for full-year 2020

Ad hoc Announcement according to Art. 17 Market Abuse Regulation

QIAGEN reports strong preliminary results for third quarter of 2020

QIAGEN to complement COVID-19 testing portfolio with novel kit that simplifies and accelerates PCR analysis for research applications

QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems

QIAGEN to launch rapid portable test that can analyze over 30 samples per hour for SARS-CoV-2 antigen

The following press release is in German language only - QIAGEN investiert mehr als 110 Mio. Euro in die Erhöhung der Produktions-kapazitäten für Coronavirus-Tests

QIAGEN to launch easy-to-use digital test in the U.S. for rapid detection of SARS-CoV-2 antibodies following FDA emergency use authorization

Ad hoc Announcement according to Art. 17 Market Abuse Regulation

QIAGEN announces new Chairman of Supervisory Board